共 113 条
- [1] Bushby K(2010)Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management Lancet Neurol 9 77-93
- [2] Finkel R(2013)Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy PLoS One 8 e81302-2414
- [3] Birnkrant DJ(2006)Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects Exp Cell Res 312 2401-151
- [4] Case LE(2007)A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs PLoS Genet 3 e79-1192
- [5] Clemens PR(2011)The role of myostatin in muscle wasting: an overview J Cachexia Sarcopenia Muscle 2 143-421
- [6] Cripe L(1984)Chromosome-linked muscular dystrophy (mdx) in the mouse Proc Natl Acad Sci U S A 81 1189-549
- [7] Finkel RS(2002)Functional improvement of dystrophic muscle by myostatin blockade Nature 420 418-971
- [8] Flanigan KM(2005)Myostatin propeptide-mediated amelioration of dystrophic pathophysiology FASEB J 19 543-1297
- [9] Wong B(2003)Inhibition of myostatin in adult mice increases skeletal muscle mass and strength Biochem Biophys Res Commun 300 965-1318
- [10] Bonnemann C(2011)Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy Am J Pathol 178 1287-707